Immutable evidence record · ticker

MoonLake Immunotherapeutics (MLTX)

Published as observed on 18 August 2026 at 10:40 BST.

MoonLake Immunotherapeutics has a balanced company news read. Its latest completed weekly trend is positive.

As of
18 Aug 2026, 10:40
Scope
company and instrument
Evidence
15 items
Independent sources
5
Country
United States
Sector
Healthcare
Previous read
50.000
Change

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, MoonLake Immunotherapeutics (MLTX), 2026-08-18, https://sharemaestro.com/evidence/cd411c7d-bd93-44ac-91f1-aa48399de292/
Record checksum be65f138e255374b67e2cba4734aa3e325df6552203df43f62460ebd69046996

Evidence context